The RA Patient With Multiple Treatment Failures

Title:

The RA Patient With Multiple Treatment Failures

Topic: Rheumatology
Relevant Terms: Rheumatoid Arthritis
Primary Audience: Rheumatologists, Rheumatology Nurses
Launch Date: 24-Sep-13
Credits: 0.75 AMA PRA Category 1 Credit
0.75 ANCC contact hour
1 CA-BRN contact hour
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Managing a Non-Responder to Methotrexate

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Implement evidence-based guidelines into practice as warranted for the treatment of specific subsets of patients with rheumatoid arthritis (RA)
  2. Implement and/or optimize the utilization of target-based patient management within the next 3 months to standardize patient care and optimize overall outcomes

    Faculty

    Neal Birnbaum, MD, FACP, MACR
    Director, Division of Rheumatology
    California Pacific Medical Center
    San Francisco, CA
    Vivian Bykerk, MD
    Assistant Attending Rheumatologist
    Hospital for Special Surgery
    New York, NY
    Jacqueline Fritz, RN, MSN, CNS
    Medical Advancement Center
    Critical Care and Rheumatology Specialist
    Cypress, California
    Instructions on How to Receive Credit
    • Participants must review the materials on accreditation information, target audience, learning objectives, and disclosure information.
    • Complete the entire activity, pre/post-test and evaluation.
    • After passing the post-test, print out your electronic CE certificate.
    • In order to successfully complete this activity learners must achieve a minimum of 65% on the post-test.
    This activity is supported by an unrestricted educational grant from AbbVie, Bristol-Myers Squibb, and UCB, Inc.

    This activity is sponsored by the Institute for Continuing Healthcare Education

    Release Date: September 24, 2013
    Expiration Date: September 24, 2014

     
    Accreditation Statements
    Physicians
    The Institute for Continuing Healthcare Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    The Institute for Continuing Healthcare Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Nurses
    The Institute for Continuing Healthcare Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    This activity offers 0.75 contact hours to participating nurses. This credit may be applied toward licensure requirements in those states that recognize American Nurses Credentialing Center's Commission on Accreditation (ANCC-COA) accredited providers.

    Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.

    California Nurses
    The Institute for Continuing Healthcare Education is approved by the California Board of Registered Nursing, Provider Number 13313. The Institute for Continuing Healthcare Education approves this activity for 1.0 contact hours.
     
    Disclosure
    Relationships are abbreviated as follows: E, Educational Planning Committee; G, Grant/research support recipient; A, Advisor/review panel member/educational planning committee; C, Consultant/Independent Contractor; SS, Stock shareholder; SB, Speaker bureau; PE, Promotional Event Talks; H, Honoraria; O, Other.

    Faculty
    Neil Birnbaum, MD 
    California Pacific Medical Center
    San Francisco, CA


    Dr. Birnbaum has disclosed the following relevant financial relationships in the past 12 months: Janssen, Amgen, Pfizer,& Abbott/PE.

    Vivian Bykerk, MD
    Hospital for Special Surgery
    New York, NY


    Dr. Bykerk has disclosed the following relevant financial relationships that have occurred within the past 12 months: Amgen, Antares, Astellas, BMS, Genentech, Merck, and UCB/A, Novartis,/SS.

    Jacqueline M. Fritz, RN, MSN, CSN 
    Medical Advancement Center
    Cypress, CA

    Ms. Fritz has disclosed the following relevant financial relationships that has occurred within the past 12 months: Institute for Continuing Healthcare Education and UCB/A; Amgen, UCB, Genentech, Johnson & Johnson, Savient/SB; Amgen, UCB, Genentech, Johnson & Johnson, Savient/PE.

    Medical Writer
    Eve Wilson, PhD, CCMEP, ELS
    Morphos Medical Education, LLC
    Bowie, MD

    Dr. Wilson has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.

    Peer Reviewer
    Stanford Peng, MD
     
    Virginia Mason Medical Center
    Seattle, WA


    Dr. Peng has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of this activity.

    Activity Development and Management Team
    Cathy Pagano, CCMEPAllison A. Muller, Pharm.D, D.ABATScott Kober, MBA, CCMEPApril Reynolds, MS, ELSSandra Davidson; and Megan Small are employees of the Institute and have no relationships to disclose.

    Off-label Product Disclosure
    This educational activity includes discussion of published and/or investigational uses of agents that are not indicated by the U.S. Food and Drug Administration. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
    Google Chrome 18.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 13.0+ for Windows, Mac OS, or Linux
    Safari 4.0+ for Mac OSX 10.5 and above
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above

     

    For additional technical support, please send an email to msmall@iche.edu.

    General Disclosure and Copyright Statement
    The opinions expressed in this publication are those of the participating faculty and not those of the Institute for Continuing Healthcare Education (the Institute), AbbVie, Bristol-Myers Squibb, or UCB, Inc., or any manufacturers of products mentioned herein.

    This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional regarding diagnostic and treatment options of a specific patient's medical condition. In no event will the Institute be responsible for any decision made or action taken based upon the information provided in this activity.

    Participants are encouraged to consult the package insert for all products for updated information and changes regarding indications, dosages, and contraindications. This recommendation is particularly important for new or infrequently used products.

    Copyright 2013. Institute for Continuing Healthcare Education (the Institute). All rights reserved. No part of this publication may be reproduced or transmitted in any other form or by any means electronic or mechanical—without first obtaining written permission from the Institute.
     
    The Institute reserves the right to cancel or modify the activity content, faculty, and activities if necessary.